What is Emerald Health Therapeutics, Inc. (EMHTF) stock price today?

Emerald Health Therapeutics, Inc. (EMHTF) is currently trading at $0.04, up 33.33% today.

What is EMHTF P/E ratio?

Emerald Health Therapeutics, Inc.'s P/E ratio is -0.19. This is below the market average, suggesting the stock may be undervalued relative to earnings.

What is EMHTF return on equity (ROE)?

Emerald Health Therapeutics, Inc.'s return on equity (ROE) is -117.65%, indicating how efficiently the company generates profit from shareholders' equity. This is below the typical market average of 12-15%.

OTC · Drug Manufacturers - Specialty & Generic

Emerald Health Therapeutics, Inc. (EMHTF) Stock

$0.04 +33.33% OTC: EMHTF Healthcare

Emerald Health Therapeutics, Inc. (EMHTF) is a Canadian entity engaged in the cultivation, distribution, and sale of cannabis for both recreational and medical markets throughout Canada.

Valuation

Metric	Value
Price	$0.04
Market Cap	$0
P/E Ratio	-0.19
P/B Ratio	0.33
P/S Ratio	0.00
EPS (TTM)	$-0.21
52-Week High	$0.07
52-Week Low	$0.02
Dividend Yield	0.00%

Financials & Margins

Metric	Value
ROE	-117.65%
ROA	-97.56%
ROCE	-114.18%
Gross Margin	-380.00%
Operating Margin	-380.00%
Net Margin	-400.00%
Debt/Equity	0.12
Current Ratio	3.14

Annual Financials (USD)

Metric	2017	2018	2019	2020	2021
Revenue	$1.0M	$2.0M	$20.0M	$12.0M	$10.0M
Operating Profit	$-9.0M	$-30.0M	$-112.0M	$-38.0M	$-38.0M
Net Profit	$-9.0M	$-31.0M	$-112.0M	$-44.0M	$-40.0M
EPS	$-0.10	$-0.22	$-0.76	$-0.23	$-0.21
Op Margin	-931.3%	-1559.7%	-552.4%	-321.8%	-397.4%

Balance Sheet (USD)

Metric	2017	2018	2019	2020	2021
Total Assets	$74.0M	$207.0M	$157.0M	$98.0M	$41.0M
Total Liabilities	$6.0M	$36.0M	$53.0M	$26.0M	$7.0M
Cash	$45.0M	$36.0M	$3.0M	$26.0M	$19.0M
Borrowings	$0	$3.0M	$28.0M	$4.0M	$4.0M

Latest News

Micron and Sandisk Are Surging: Can the Rally Last Through 2027? Motley Fool · Jul 23, 2026 Net Asset Value(s) Business Wire · Jul 23, 2026 Retiring With Lots of Savings? 2 Social Security Claiming Strategies to Look At. Motley Fool · Jul 23, 2026 Arista Networks Insider Sold Shares Worth $7,388,872, According to a Recent SEC Filing MT Newswires · Jul 23, 2026 Go Global, Go Systemic: China Asset Management Unveils Active Investment Research 5.0 GlobeNewswire · Jul 23, 2026

Cash Flow (USD)

Metric	2017	2018	2019	2020	2021
Operating Cash Flow	$-8.0M	$-29.0M	$-25.0M	$-11.0M	$-17.0M
Investing Cash Flow	$-21.0M	$-81.0M	$-68.0M	$51.0M	$19.0M
Financing Cash Flow	$68.0M	$83.0M	$35.0M	$-20.0M	$-10.0M
Net Cash Flow	$41.0M	$-8.0M	$-34.0M	$23.0M	$-7.0M
Free Cash Flow	$-10.0M	$-48.0M	$-49.0M	$-14.0M	$-18.0M

Valuation & Return Ratios

Metric	Value
PEG Ratio	-0.01
EV / EBITDA	0.42
FCF Yield	—
Quick Ratio	2.96
Interest Coverage	-54.95
Return 1Y	—
Return 3Y	—
Return 5Y	—

Peer Comparison

Ticker	Price	Change	P/E	Market Cap	Div Yield
BNOEFBionomics Limited	$0.01	-14.89%	-0.30	$8.81M	0.00%
CNPOFRIV Capital Inc.	$0.08	+0.00%	-0.15	$10.96M	0.00%
FLWPFThe Flowr Corporation	$0.00	—	—	$4265	0.00%
HBCNFHealthBeacon plc	$0.50	+2269.67%	-0.57	$8.44M	0.00%
IMUNImmune Therapeutics, Inc.	$0.09	-7.00%	-0.56	$7.78M	0.00%

About Emerald Health Therapeutics, Inc.

Emerald Health Therapeutics, Inc. (EMHTF) is a Canadian entity engaged in the cultivation, distribution, and sale of cannabis for both recreational and medical markets throughout Canada. The company offers a wide range of cannabis products, including dried flower, pre-rolls, oral sprays, advanced nano emulsion beverages, and various cannabis oil formulations. These products are marketed under distinct brands such as SYNC Wellness, fuse, Emerald, and Souvenir. Initially founded as T-Bird Pharma Inc., the organization rebranded to Emerald Health Therapeutics, Inc. in June 2015. Headquartered in Vancouver, Canada, Emerald Health Therapeutics, Inc. has been operating as a subsidiary of Skye Bioscience, Inc. since November 10, 2022.

the stock is valued at a price-to-earnings (P/E) ratio of -0.19, price-to-book of 0.33, price-to-sales of 0.00. Over the past 52 weeks the stock has ranged between $0.02 and $0.07, and currently trades 42.9% below its 52-week high.

On profitability, Emerald Health Therapeutics, Inc. generates a return on equity (ROE) of -117.65%, return on capital employed of -114.18%, an operating margin of -380.00%, a net profit margin of -400.00%.

Official website: emeraldhealth.ca

Related Healthcare Stocks

LLY Eli Lilly and Company $1214.57 +4.12% JNJ Johnson & Johnson $252.50 +1.56% ABBV AbbVie Inc. $283.27 +3.25% MRK Merck & Company, Inc. Common Stock (new) $145.97 +2.81% UNH UnitedHealth Group Incorporated Common Stock (DE) $391.45 +3.62% NVS Novartis AG $145.21 +1.97% AZN AstraZeneca PLC $161.76 +3.81% TMO Thermo Fisher Scientific Inc $672.75 +1.46% AMGN Amgen Inc. $424.60 +2.85% GILD Gilead Sciences, Inc. $151.51 +2.43% ABT Abbott Laboratories $102.16 -0.44% NVO Novo Nordisk A/S $38.17 +0.30%

Screens featuring this stock

High ROE Healthcare Stocks Low P/E Healthcare Stocks High Net Margin Healthcare Stocks Dividend Healthcare Stocks Low Debt Healthcare Stocks All stock screens

Run Stock Screener Investing Guides